Septic shock is defined as a subset of sepsis with circulatory and cellular/metabolic dysfunction associated with a higher risk of mortality. Better cardiovascular management in septic shock can help improve septic shock management. Vasopressin and landiolol are critical therapies for ensuring the vascular and cardiac systems are as close to optimal conditions as possible during septic shock.
In this webinar, you will be able to listen from the experts on how vasopressin and landiolol lead to better patient outcomes and, improve patient survival.
Aims & Objectives
- Learn how to optimise vasopressin initiation in septic shock
- Discuss the role of Landiolol in septic shock
Topics & Speakers
“Optimizing vasopressin initiation in septic shock“
Arthur VAN ZANTEN
Gelderse Vallei Hospital, Ede (NL)
“Role of Landiolol, a short acting betablocker, in septic shock”
Alexandroupolis University Hospital (GR)
Professor, APHP and Université de Paris (FR)
Thanks to the support of